Effects of a monoclonal anti-αvβ3 integrin antibody on blood vessels—A pharmacodynamic study

Author： Zhang Dahua   Pier Thomas   McNeel Douglas   Wilding George   Friedl Andreas  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.25, Iss.1, 2007-02, pp. : 49-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Natalizumab: AN 100226, Anti-4 Integrin Monoclonal Antibody

By Adis International Limited  

Drugs in R&D, Vol. 5, Iss. 2, 2004-01 ,pp. : 102-107

Adis International

Access to resources Recommend Favorite

Ligands to the integrin receptor αvβ3

By Duong Le T   Coleman Paul J  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 7, 2002-07 ,pp. : 1009-1021

Informa Healthcare

Access to resources Recommend Favorite

Integrated pharmacokinetic-pharmacodynamic modeling and allometric scaling for optimizing the dosage regimen of the monoclonal ior EGF/r3 antibody

By Duconge J.   Castillo R.   Crombet T.   Alvarez D.   Matheu J.   Vecino G.   Alonso K.   Beausoleil I.   Valenzuela C.   Becquer M.A.   Fernandez-Sanchez E.  

European Journal of Pharmaceutical Sciences, Vol. 21, Iss. 2, 2004-02 ,pp. : 261-270

Elsevier

Access to resources Recommend Favorite

Osteopontin and αvβ3 integrin expression in the endometrium of infertile and fertile women

By Casals Gemma   Ordi Jaume   Creus Montserrat   Fábregues Francisco   Casamitjana Roser   Quinto Llorenç   Campo Elias   Balasch Juan  

Reproductive BioMedicine Online, Vol. 16, Iss. 6, 2008-06 ,pp. : 808-816

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Integrin v&bgr;3 as a Therapeutic Target for Blocking Tumor-Induced Angiogenesis

By  

Current Drug Targets, Vol. 4, Iss. 2, 2003-02 ,pp. : 123-131

Bentham Science Publishers

Access to resources Recommend Favorite